John V. Heymach

The University of Texas MD Anderson Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

4.4Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer

Nature Genetics(2023)10.1038/s41588-023-01355-5

Top 6%

4.0DataRank

Top 6%188 citations

Matthew D. Hellmann, Monica Arniella, Mark Holton, Samuel S. Freeman, Vivek Naranbhai +37 more

Papers

Driven by 129 papers — median percentile 72. Top paper: “Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status”.

Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.10.013

N/A

8.9DataRank · unranked

377 citations

Kathryn C. Arbour, W. Marston Linehan, Amir Vajdi, Natalie I. Vokes, Lingzhi Hong +28 more

Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.04.026

N/A

6.8DataRank · unranked

195 citations

Marcelo V. Negrão, Seyedeh Dibaj, Runzhe Chen, Alexandre Reuben, Jadi M. Bohac +32 more

Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery

The Lancet Oncology(2021)10.1016/s1470-2045(21)00401-0

N/A

6.1DataRank · unranked

319 citations

Reza J. Mehran, Lei Feng, Vivek Verma, Zhongxing Liao, James W. Welsh +30 more

Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial

The Lancet(2023)10.1016/s0140-6736(23)01384-3

N/A

5.0DataRank · unranked

230 citations

Steven H. Lin, Wenli Dong, Zhongxing Liao, Saumil Gandhi, Carl M. Gay +23 more

Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001001

N/A

4.9DataRank · unranked

289 citations

Hari Menon, Dawei Chen, Vivek Verma, Chad Tang, Mehmet Altan +12 more

Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

Nature Medicine(2023)10.1038/s41591-022-02189-0

N/A

4.1DataRank · unranked

213 citations

Cheuk Hong Leung, Annikka Weissferdt, Apar Pataer, Brett W. Carter, Myrna C. B. Godoy +52 more

Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer

Nature Genetics(2023)10.1038/s41588-023-01355-5

Top 6%

4.0DataRank

Top 6%188 citations

Matthew D. Hellmann, Monica Arniella, Mark Holton, Samuel S. Freeman, Vivek Naranbhai +37 more

Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivity

Cancer Cell(2022)10.1016/j.ccell.2022.06.006

N/A

3.9DataRank · unranked

106 citations

Jacqulyne Robichaux, Brett W. Carter, Mehmet Altan, Hai T. Tran, Don L. Gibbons +22 more

Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer

Nature Communications(2021)10.1038/s41467-021-25188-0

N/A

3.1DataRank · unranked

110 citations

Annikka Weissferdt, Myrna C. B. Godoy, William N. William, Cheuk Hong Leung, Heather Lin +23 more

Giant Circulating Cancer-Associated Macrophage-Like Cells Are Associated With Disease Recurrence and Survival in Non–Small-Cell Lung Cancer Treated With Chemoradiation and Atezolizumab

Clinical Lung Cancer(2020)10.1016/j.cllc.2020.06.016

N/A

1.1DataRank · unranked

39 citations

Daniel L. Adams, Jianzhong He, Yawei Qiao, Vivek Verma, Zhongxing Liao +5 more

Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study

Molecular Cancer(2024)10.1186/s12943-024-02014-x

N/A

0.975DataRank · unranked

43 citations

Miljenka Vuko, Jaime Rodriguez‐Canales, Johannes Zimmermann, Markus Schick, Cathy O’Brien +13 more

Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance

Nature Medicine(2023)10.1038/s41591-023-02371-y

N/A

0.933DataRank · unranked

501 citations

Enyu Dai, Yating Li, Guangchun Han, Guangsheng Pei, Davis R. Ingram +39 more

Structure-based classification predicts drug response in EGFR-mutant NSCLC

Nature(2021)10.1038/s41586-021-03898-1

N/A

0.922DataRank · unranked

467 citations

Xiuning Le, R. S. K. Vijayan, J. Kevin Hicks, Simon Heeke, Yasir Y. Elamin +28 more

Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002891

N/A

0.854DataRank · unranked

296 citations

Ferdinandos Skoulidis, Meagan Montesion, Katja Schulze, Ilze Bāra, Vincent K. Shen +33 more

Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1420

N/A

0.787DataRank · unranked

189 citations

Haniel A. Araújo, Giuseppe Lamberti, Alissa J. Cooper, Neal S. Akhave, Teng Zhou +61 more

Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience

The Oncologist(2023)10.1093/oncolo/oyad118

N/A

0.768DataRank · unranked

26 citations

Felipe Soto, Linda Zhong, Fechukwu Akhmedzhanov, Nathaniel R. Wilson, Abdulrazzak Zarifa +23 more

Concurrent TP53 Mutations Facilitate Resistance Evolution in EGFR-Mutant Lung Adenocarcinoma

Journal of Thoracic Oncology(2022)10.1016/j.jtho.2022.02.011

N/A

0.764DataRank · unranked

162 citations

Emily S. Chambers, Tom Nguyen, Alexis Coolidge, Christine Lydon, Xiuning Le +6 more

Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study

The Lancet Digital Health(2023)10.1016/s2589-7500(23)00082-1

N/A

0.708DataRank · unranked

111 citations

Lingzhi Hong, Muhammad Aminu, Natalie I. Vokes, Pingjun Chen, Morteza Salehjahromi +44 more

Dissecting the clinicopathologic, genomic, and immunophenotypic correlates of KRASG12D-mutated non-small-cell lung cancer

Annals of Oncology(2022)10.1016/j.annonc.2022.07.005

N/A

0.701DataRank · unranked

106 citations

Joao V. Alessi, Arielle Elkrief, Xinan Wang, Alessio Cortellini, Y Y Li +27 more

Radiological tumour classification across imaging modality and histology

Nature Machine Intelligence(2021)10.1038/s42256-021-00377-0

N/A

0.685DataRank · unranked

95 citations

Chao Li, Michael F. Gensheimer, Sukhmani K. Padda, Fumi Kato, Hiroki Shirato +11 more

Genotype-Specific Differences in Circulating Tumor DNA Levels in Advanced NSCLC

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.12.011

N/A

0.678DataRank · unranked

91 citations

Jianjun Zhang, Carol C. Wu, Hai T. Tran, Lerong Li, Lixia Diao +13 more

Enhancing NSCLC recurrence prediction with PET/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insights

Nature Communications(2024)10.1038/s41467-024-47512-0

N/A

0.672DataRank · unranked

87 citations

Muhammad Aminu, Tatiana V. Karpinets, Pingjun Chen, Maliazurina B. Saad, Morteza Salehjahromi +32 more

Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancer

Annals of Oncology(2023)10.1016/j.annonc.2023.11.008

N/A

0.646DataRank · unranked

73 citations

Simon Heeke, Sheeba J. Sujit, Natalie I. Vokes, J. Zhang, Muhammad Aminu +10 more

Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-1744

N/A

0.641DataRank · unranked

71 citations

Jianjun Zhang, Jiayin Wang, Alexandre Reuben, Wei Xu, Xin Yi +23 more

Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non–small cell lung cancer and a poor performance status

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001007

N/A

0.614DataRank · unranked

59 citations

Biagio Ricciuti, E. Jimenez-Aguilar, Fangxin Hong, Zihan Wei, Mizuki Nishino +10 more

Lung Cancer Models Reveal Severe Acute Respiratory Syndrome Coronavirus 2–Induced Epithelial-to-Mesenchymal Transition Contributes to Coronavirus Disease 2019 Pathophysiology

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.07.002

N/A

0.609DataRank · unranked

57 citations

Carl M. Gay, Kavya Ramkumar, Kasey R. Cargill, Robert J. Cardnell, Monique B. Nilsson +23 more

Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer

Nature Communications(2021)10.1038/s41467-021-26821-8

N/A

0.598DataRank · unranked

53 citations

Runzhe Chen, Ying Jin, Jun Li, Xin Hu, Jiexin Zhang +40 more

Evaluation of Pathologic Response in Lymph Nodes of Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.03.029

N/A

0.581DataRank · unranked

47 citations

Annikka Weissferdt, Ara A. Vaporciyan, Arlene M. Correa, Boris Sepesi, Ignacio I. Wistuba +4 more

Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101463

N/A

0.546DataRank · unranked

37 citations

Tatiana V. Karpinets, Sheeba J. Sujit, Mohamed Qayati, Pingjun Chen, Muhammad Aminu +32 more

Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1207

N/A

0.542DataRank · unranked

36 citations

Biagio Ricciuti, Chaitanya Bandlamudi, Daniel M. Muldoon, Hira Rizvi, Arielle Elkrief +23 more

Pathomic Features Reveal Immune and Molecular Evolution From Lung Preneoplasia to Invasive Adenocarcinoma

Modern Pathology(2023)10.1016/j.modpat.2023.100326

N/A

0.533DataRank · unranked

34 citations

Frank Rojas, Xin Hu, Alejandra G. Serrano, Bo Zhu, Hong Chen +23 more

Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trial

Lung Cancer(2022)10.1016/j.lungcan.2022.10.006

N/A

0.529DataRank · unranked

33 citations

Luyang Yao, Neda Kalhor, Brett W. Carter, Mehmet Altan, George Blumenschein +14 more

Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network

UNC Libraries(2020)10.17615/s7re-zq82

N/A

0.520DataRank · unranked

31 citations

Marc Ladanyi, William Lee, David G. Beer, Bryan Hernandez, David J. Kwiatkowski +27 more

High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastatic NSCLC

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-008950

N/A

0.515DataRank · unranked

13 citations

Ruoxing Li, Ziyi Li, Runzhe Chen, Ajay Sheshadri, Hai T. Tran +12 more

Molecular markers of metastatic disease in KRAS-mutant lung adenocarcinoma

Annals of Oncology(2023)10.1016/j.annonc.2023.04.514

N/A

0.510DataRank · unranked

29 citations

Christine Lydon, Emily S. Chambers, Lynette M. Sholl, Mizuki Nishino, Ferdinandos Skoulidis +8 more

Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) study

npj Precision Oncology(2021)10.1038/s41698-021-00159-2

N/A

0.505DataRank · unranked

28 citations

David S. Hong, Siqing Fu, Daniel D. Karp, Sarina A. Piha‐Paul, Merrill S. Kies +16 more

Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception

Cancer Cell(2025)10.1016/j.ccell.2025.04.003

N/A

0.505DataRank · unranked

28 citations

Pingjun Chen, Muhammad Aminu, Jiànróng Lǐ, Junya Fujimoto, Yanhua Tian +47 more

Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From EGFR-Mutant NSCLC Informs Potential Therapeutic Targets

JTO Clinical and Research Reports(2023)10.1016/j.jtocrr.2023.100623

N/A

0.504DataRank · unranked

12 citations

Whitney E. Lewis, C. Allison Stewart, Benjamin B. Morris, Luisa M. Solis, Alejandra G. Serrano +31 more

Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC

Journal of Thoracic Oncology(2023)10.1016/j.jtho.2023.11.020

N/A

0.494DataRank · unranked

26 citations

Robyn Du, Nathaniel J. Myall, Whitney E. Lewis, Natalie Uy, Lingzhi Hong +22 more

Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors

Annals of Oncology(2024)10.1016/j.annonc.2024.11.014

N/A

0.489DataRank · unranked

25 citations

Lingzhi Hong, Arielle Elkrief, Rohit Thummalapalli, Alissa J. Cooper, Biagio Ricciuti +43 more

Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non–small cell lung cancer

Cancer(2023)10.1002/cncr.34820

N/A

0.488DataRank · unranked

9 citations

Janet Tu, Denái R. Milton, Bülent Yılmaz, Yanyan Tian, Frank V. Fossella +8 more

BRAF v600E–mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study

npj Precision Oncology(2023)10.1038/s41698-022-00341-0

N/A

0.470DataRank · unranked

22 citations

Jason Roszik, Filip Jankú, David S. Hong, Shumei Kato, Aung Naing +11 more

Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations

BMC Cancer(2020)10.1186/s12885-020-6579-z

N/A

0.464DataRank · unranked

21 citations

Junsheng Ma, Abha Khanna, Genevieve Lyons, Waree Rinsurongkawong, Roland L. Bassett +12 more

Estrogen Promotes Resistance to Bevacizumab in Murine Models of NSCLC

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.07.007

N/A

0.457DataRank · unranked

20 citations

Matthew H. Herynk, Tina Cascone, Babita Saigal, Monique B. Nilsson, Hai T. Tran +8 more

Resolving the spatial and cellular architecture of lung adenocarcinoma by multi-region single-cell sequencing

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.04.283739

N/A

0.442DataRank · unranked

18 citations

Guangchun Han, Warapen Treekitkarnmongkol, Kieko Hara, Patrick M. Brennan, Minghao Dang +36 more

Metabolic and Functional Genomic Studies Identify Deoxythymidylate Kinase as a Target in LKB1-Mutant Lung Cancer

UNC Libraries(2020)10.17615/ge7q-0q17

N/A

0.442DataRank · unranked

18 citations

Sean T. Bailey, David J. Kwiatkowski, Pasi A. Jänne, Jeffrey A. Engelman, Julián Carretero +35 more

YAP1 Status Defines Two Intrinsic Subtypes of LCNEC with Distinct Molecular Features and Therapeutic Vulnerabilities

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0361

N/A

0.434DataRank · unranked

17 citations

Lixia Diao, Yuanxin Xi, Runsheng Wang, Kavya Ramkumar, Alejandra G. Serrano +24 more

SwarmDeepSurv: swarm intelligence advances deep survival network for prognostic radiomics signatures in four solid cancers

Patterns(2023)10.1016/j.patter.2023.100777

N/A

0.416DataRank · unranked

15 citations

Maliazurina B. Saad, Ajay Sheshadri, Carol C. Wu, Joe Y. Chang, Bissan Al‐Lazikani +9 more

Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study

ESMO Open(2021)10.1016/j.esmoop.2021.100079

N/A

0.396DataRank · unranked

13 citations

Ruth Sacks, Ishwaria M. Subbiah, Neele Drobnitzky, Sarina A. Piha‐Paul, David S. Hong +15 more

Distinct Clinicogenomic Features and Immunotherapy Associations in Pulmonary Sarcomatoid Carcinoma: A Multicenter Retrospective Study

Journal of Thoracic Oncology(2025)10.1016/j.jtho.2025.07.121

N/A

0.373DataRank · unranked

11 citations

Alessandro Di Federico, Bolun Liu, Alissa J. Cooper, Joao V. Alessi, Phoebe Clark +25 more

Impact of genomic aberrations and additional therapies on survival outcomes of patients with operable non-small cell lung cancer (NSCLC) from the NEOSTAR study.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.8542

Top 49%

0.359DataRank

Top 49%3 citations

Boris Sepesi, Cheuk Hong Leung, Heather Lin, William Nassib William, Annikka Weissferdt +15 more

Distinct patterns of auto-reactive antibodies associated with organ-specific immune-related adverse events

Frontiers in Immunology(2023)10.3389/fimmu.2023.1322818

N/A

0.357DataRank · unranked

6 citations

Quan‐Zhen Li, Qi Wang, Natalie I. Vokes, Ajay Sheshadri, Jianjun Gao +14 more

First-Line MET Tyrosine Kinase Inhibitors versus Immunotherapy ± Chemotherapy for Patients with MET Exon 14 Skipping Mutant Metastatic NSCLC

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-1735

N/A

0.345DataRank · unranked

9 citations

Hui Li, Alessandro Di Federico, Jia Wu, Hong Chen, Eleonora Gariazzo +26 more

Integrative genomic and transcriptomic profiling of pulmonary sarcomatoid carcinoma identifies molecular subtypes associated with distinct immune features and clinical outcomes

Cancer Innovation(2024)10.1002/cai2.112

N/A

0.330DataRank · unranked

8 citations

Runzhe Chen, Yang Liu, Junya Fujimoto, Lingzhi Hong, Alexandre Reuben +20 more

Immunogenomic intertumor heterogeneity across primary and metastatic sites in a patient with lung adenocarcinoma

Journal of Experimental & Clinical Cancer Research(2022)10.1186/s13046-022-02361-x

N/A

0.312DataRank · unranked

7 citations

Jun Li, Junya Fujimoto, Lingzhi Hong, Xin Hu, Kelly Quek +18 more

Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLC

Nature Communications(2025)10.1038/s41467-025-61823-w

N/A

0.312DataRank · unranked

7 citations

Qasem Al-Tashi, Lingzhi Hong, Vivek Verma, Wentao Li, Daniel Boiarsky +32 more

Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable locally advanced non-small cell lung carcinoma

Radiotherapy and Oncology(2024)10.1016/j.radonc.2024.110121

N/A

0.304DataRank · unranked

5 citations

Ting Xu, Yuki Sasaki, Ruitao Lin, Aileen B. Chen, James W. Welsh +18 more

Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non–Small Cell Lung Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1591

N/A

0.292DataRank · unranked

6 citations

Gilberto Lopes, T. Jeroen N. Hiltermann, Ramaswamy Govindan, Liza C. Villaruz, Emiliano Calvo +19 more

The Activity of EGFR CAR NK and CAR T Cells against EGFR Inhibitor–Resistant NSCLC and Drug-Tolerant Persister Cells

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-1693

N/A

0.241DataRank · unranked

4 citations

Monique B. Nilsson, Xiaoxing Yu, Alissa Poteete, Hong Jiang, Qian Huang +4 more

Causal AI-based clinical and radiomic analysis for optimizing patient selection in combined immunotherapy and SABR in early-stage NSCLC: a secondary analysis of the phase II I-SABR trial

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-013074

N/A

0.241DataRank · unranked

4 citations

Eman Showkatian, Vivek Verma, Qasem Al-Tashi, Muhammad Aminu, Xinyan Xu +17 more

Joint multi-omics discriminant analysis with consistent representation learning using PANDA

Research Square(2024)10.21203/rs.3.rs-4353037/v1

N/A

0.217DataRank · unranked

2 citations

Muhammad Aminu, Lingzhi Hong, Natalie I. Vokes, Stephanie Schmidt, Maliazurina B. Saad +15 more

Th2 Cells Are Associated with Tumor Recurrence Following Radiation

Cancers(2024)10.3390/cancers16081586

N/A

0.208DataRank · unranked

3 citations

Riyue Bao, Phillip M. Pifer, David Molkentine, Jessica M. Molkentine, Andrew Hefner +9 more

Comparison of imaging-based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed, paraffin-embedded tumor samples

Research Square(2025)10.21203/rs.3.rs-5656204/v1

N/A

0.104DataRank · unranked

1 citations

Nejla Ozirmak Lermi, Max Molina Ayala, Sharia Hernandez, Wei Lu, Khaja Khan +25 more

Radiomics for Dynamic Lung Cancer Risk Prediction in USPSTF-Ineligible Patients

Cancers(2025)10.3390/cancers17213406

N/A

0.104DataRank · unranked

1 citations

Hui Li, Eman Showkatian, Maliazurina B. Saad, Mohamed Qayati, Sohair Ismail +25 more

Development of PET/CT-clinical nomograms for predicting lymph node metastasis in primary lung cancer

European Radiology(2025)10.1007/s00330-025-12166-z

N/A

0DataRank · unranked

0 citations

Wentao Li, Julie Lin, Shuoyang Li, Maliazurina B. Saad, Yuliya Kitsel +17 more

Comparison of imaging based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed paraffin-embedded tumor samples

Nature Communications(2025)10.1038/s41467-025-63414-1

N/A

0DataRank · unranked

24 citations

Max Molina Ayala, Sharia Hernandez, Wei Lu, Khaja Khan, Alejandra G. Serrano +69 more

A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components

Science Translational Medicine(2020)10.1126/scitranslmed.aaz4589

N/A

0DataRank · unranked

181 citations

Huiying Sun, Jacqulyne Robichaux, Matthias Pfeifer, Ultan McDermott, Jon Travers +19 more

IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.01.005

N/A

0DataRank · unranked

460 citations

Sanja Đačić, Ignacio I. Wistuba, Lynette M. Sholl, Prasad S. Adusumilli, Lukas Bubendorf +38 more

Characterization of the Immune Landscape of EGFR-Mutant NSCLC Identifies CD73/Adenosine Pathway as a Potential Therapeutic Target

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.12.010

N/A

0DataRank · unranked

126 citations

Marcelo V. Negrão, Alexandre Reuben, Lorenzo Federico, Lixia Diao, Daniel J. McGrail +34 more

Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy

Clinical Lung Cancer(2020)10.1016/j.cllc.2019.11.003

N/A

0DataRank · unranked

114 citations

Apar Pataer, Ara A. Vaporciyan, Arlene M. Correa, Boris Sepesi, César A. Moran +10 more

Phase 1/2 Trial of Pembrolizumab and Concurrent Chemoradiation Therapy for Limited-Stage SCLC

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.08.022

N/A

0DataRank · unranked

98 citations

John V. Heymach, Chunxiao Guo, Hari Menon, Katherine Klein, Taylor R. Cushman +19 more

Molecular Landscape of BRAF-Mutant NSCLC Reveals an Association Between Clonality and Driver Mutations and Identifies Targetable Non-V600 Driver Mutations

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.05.021

N/A

0DataRank · unranked

73 citations

Victoria M. Raymond, Richard B. Lanman, Jacqulyne Robichaux, Junqin He, Monique B. Nilsson +17 more

Altered Regulation of HIF-1α in Naive- and Drug-Resistant EGFR-Mutant NSCLC: Implications for a Vascular Endothelial Growth Factor-Dependent Phenotype

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.11.022

N/A

0DataRank · unranked

73 citations

Jacqulyne Robichaux, Matthew H. Herynk, Tina Cascone, Xiuning Le, Yasir Y. Elamin +17 more

Female Gender Predicts Augmented Immune Infiltration in Lung Adenocarcinoma

Clinical Lung Cancer(2020)10.1016/j.cllc.2020.06.003

N/A

0DataRank · unranked

32 citations

Pedro Rocha, Edwin R. Parra, Lei Feng, Jaime Rodriguez‐Canales, Luisa M. Solis +12 more

AXL Inhibition Induces DNA Damage and Replication Stress in Non–Small Cell Lung Cancer Cells and Promotes Sensitivity to ATR Inhibitors

Molecular Cancer Research(2020)10.1158/1541-7786.mcr-20-0414

N/A

0DataRank · unranked

55 citations

C. Allison Stewart, Kasey R. Cargill, Carminia Maria Della Corte, Qi Wang, Li Shen +10 more

LKB1/STK11 Expression in Lung Adenocarcinoma and Associations With Patterns of Recurrence

The Annals of Thoracic Surgery(2020)10.1016/j.athoracsur.2020.03.114

N/A

0DataRank · unranked

18 citations

Edwin R. Parra, Jiexin Zhang, David B. Nelson, Erin M. Corsini, Pamela Villalobos +22 more

Concurrent use of aspirin with osimertinib is associated with improved survival in advanced EGFR-mutant non-small cell lung cancer

Lung Cancer(2020)10.1016/j.lungcan.2020.08.023

N/A

0DataRank · unranked

20 citations

Lingzhi Hong, Monique B. Nilsson, Shawna M. Hubert, Shuhong Wu, Waree Rinsurongkawong +11 more

The value of interventional radiology in clinical trial teams: experience from the BATTLE lung cancer trials

Clinical Radiology(2020)10.1016/j.crad.2020.09.024

N/A

0DataRank · unranked

9 citations

Vassiliki A. Papadimitrakopoulou, Ignacio I. Wistuba, J.J. Lee, Joe Ensor, E.S. Kim +9 more

Definitive Management of Presumed Synchronous Early Stage Non-Small Cell Lung Cancers: Outcomes and Utility of Stereotactic Ablative Radiation Therapy

International Journal of Radiation Oncology*Biology*Physics(2020)10.1016/j.ijrobp.2020.02.001

N/A

0DataRank · unranked

5 citations

Matthew S. Ning, Eric D. Brooks, Jingjing Kang, James W. Welsh, Aileen B. Chen +5 more

1736P Elevated AXL expression following SARS-CoV-2 infection in non-small cell lung cancer

Annals of Oncology(2020)10.1016/j.annonc.2020.08.1800

N/A

0DataRank · unranked

2 citations

C. Allison Stewart, Carl M. Gay, Robert J. Cardnell, Li Diao, Q. Wang +9 more

Prolonged Central Nervous System Response in a Patient With HER2 Mutant NSCLC Treated With First-Line Poziotinib

JTO Clinical and Research Reports(2020)10.1016/j.jtocrr.2020.100081

N/A

0DataRank · unranked

1 citations

Bill Paxton, François Lebel, Lena Keossayan, John V. Heymach, Nishan Tchekmedyian

Lung cancer models reveal SARS-CoV-2-induced EMT contributes to COVID-19 pathophysiology

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.28.122291

N/A

0DataRank · unranked

38 citations

Carl M. Gay, Kavya Ramkumar, Kasey R. Cargill, Robert J. Cardnell, Monique B. Nilsson +23 more

Single-cell analysis of human lung epithelia reveals concomitant expression of the SARS-CoV-2 receptor ACE2 with multiple virus receptors and scavengers in alveolar type II cells

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.16.045617

N/A

0DataRank · unranked

6 citations

Ansam Sinjab, Warapen Treekitkarnmongkol, Patrick M. Brennan, Kieko Hara, Kyle Chang +27 more

1745P SARS-CoV-2 infects metabolically-primed epithelial cells in lung cancer models

Annals of Oncology(2020)10.1016/j.annonc.2020.08.1809

N/A

0DataRank · unranked

0 citations

C. Allison Stewart, Carl M. Gay, Kavya Ramkumar, Robert J. Cardnell, Monique B. Nilsson +13 more

Genomic and TCR Repertoire Intratumor Heterogeneity of Small-cell Lung Cancer and its Impact on Survival

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.30.180844

N/A

0DataRank · unranked

0 citations

Runzhe Chen, Ying Jin, Jun Li, Jiexin Zhang, Junya Fujimoto +32 more

Simplified Molecular Classification of Lung Adenocarcinomas Based on EGFR, KRAS, and TP53 Mutations

Research Square(2020)10.21203/rs.2.12804/v4

N/A

0DataRank · unranked

0 citations

Junsheng Ma, Abha Khanna, Genevieve Lyons, Waree Rinsurongkawong, Roland Bassett +12 more

Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

Cancer Cell(2021)10.1016/j.ccell.2020.12.014

N/A

0DataRank · unranked

945 citations

C. Allison Stewart, Elizabeth M. Park, Lixia Diao, Sarah M. Groves, Simon Heeke +25 more

Deep learning-based prediction of the T cell receptor–antigen binding specificity

Nature Machine Intelligence(2021)10.1038/s42256-021-00383-2

N/A

0DataRank · unranked

298 citations

Ze Zhang, James Zhu, Yunguan Wang, Peixin Jiang, Xue Xiao +8 more

Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer

Annals of Oncology(2021)10.1016/j.annonc.2021.09.021

N/A

0DataRank · unranked

137 citations

Daniel J. McGrail, Salah-Eddine Bentebibel, Cara Haymaker, Angelo Ravelli, Marie‐Andrée Forget +31 more

Resolving the Spatial and Cellular Architecture of Lung Adenocarcinoma by Multiregion Single-Cell Sequencing

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1285

N/A

0DataRank · unranked

134 citations

Guangchun Han, Warapen Treekitkarnmongkol, Kieko Hara, Patrick M. Brennan, Minghao Dang +35 more

Current and future treatment options for MET exon 14 skipping alterations in non-small cell lung cancer

Therapeutic Advances in Medical Oncology(2021)10.1177/1758835921992976

N/A

0DataRank · unranked

64 citations

Jianjun Zhang, John V. Heymach, Xiuning Le, Lingzhi Hong

Single-Cell Expression Landscape of SARS-CoV-2 Receptor ACE2 and Host Proteases in Normal and Malignant Lung Tissues from Pulmonary Adenocarcinoma Patients

Cancers(2021)10.3390/cancers13061250

N/A

0DataRank · unranked

12 citations

Ansam Sinjab, Kieko Hara, Warapen Treekitkarnmongkol, Patrick M. Brennan, Kyle Chang +26 more

Epstein Barr virus–positive B-cell lymphoma is highly vulnerable to MDM2 inhibitors in vivo

Blood Advances(2021)10.1182/bloodadvances.2021006156

N/A

0DataRank · unranked

8 citations

Ran Zhang, Chenghui Ren, Yi Xu, Shuhong Wu, Carrie Meng +19 more

Phase 3 comparison of high-dose once-daily (QD) thoracic radiotherapy (TRT) with standard twice-daily (BID) TRT in limited stage small cell lung cancer (LSCLC): CALGB 30610 (Alliance)/RTOG 0538.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.8505

N/A

0DataRank · unranked

37 citations

Xiaofei F. Wang, Gregory A. Masters, Junheng Gao, Ritsuko Komaki, Charles Kuzma +8 more

Genomic and TCR Repertoire Intratumor Heterogeneity of Small-cell Lung Cancer and its Impact on Survival

Research Square(2021)10.21203/rs.3.rs-148314/v1

N/A

0DataRank · unranked

0 citations

Runzhe Chen, Ying Jin, Jun Li, Jiexin Zhang, Junya Fujimoto +36 more

The histologic phenotype of lung cancers may be driven by transcriptomic features rather than genomic characteristics

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.01.425056

N/A

0DataRank · unranked

0 citations

Hussein A. Abbas, Marcelo V. Negrão, Maheshwari Ramineni, Xin Hu, Junya Fujimoto +24 more

Immunogenomic Intertumor Heterogeneity Across Primary and Metastatic Sites in a Patient With Lung Adenocarcinoma

Research Square(2021)10.21203/rs.3.rs-970663/v1

N/A

0DataRank · unranked

0 citations

Jun Li, Junya Fujimoto, Xin Hu, Kelly Quek, Ming Tang +17 more

Immunogenomic intertumor heterogeneity across primary and metastatic sites in a patient with lung adenocarcinoma

medRxiv(2021)10.1101/2021.08.01.21260883

N/A

0DataRank · unranked

0 citations

Jun Li, Junya Fujimoto, Xin Hu, Kelly Quek, Ming Tang +17 more

Molecular Mechanisms and Future Implications of VEGF/VEGFR in Cancer Therapy

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1366

N/A

0DataRank · unranked

451 citations

Monique B. Nilsson, Xiuning Le, Tina Cascone, Rakesh K. Jain, John V. Heymach +1 more

Immunogenomic profiling of lung adenocarcinoma reveals poorly differentiated tumors are associated with an immunogenic tumor microenvironment

Lung Cancer(2022)10.1016/j.lungcan.2022.08.007

N/A

0DataRank · unranked

22 citations

Jiexin Zhang, Erin M. Bayley, Meredith Frank, Shin‐Heng Chiou, Carmen Behrens +21 more

Major Pathologic Response and Prognostic Score Predict Survival in Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy

JTO Clinical and Research Reports(2022)10.1016/j.jtocrr.2022.100420

N/A

0DataRank · unranked

19 citations

Annikka Weissferdt, Arlene M. Correa, Ara A. Vaporciyan, Boris Sepesi, John V. Heymach +4 more

Th2 cells are associated with recurrence following radiation in human papillomavirus negative head and neck cancer.

Research Square(2022)10.21203/rs.3.rs-1537302/v1

N/A

0DataRank · unranked

1 citations

Riyue Bao, Phillip M. Pifer, David Molkentine, Jessica M. Molkentine, Andrew Hefner +9 more

Th2 cells are associated with tumor recurrence following radiation.

Research Square(2022)10.21203/rs.3.rs-1537302/v2

N/A

0DataRank · unranked

0 citations

Riyue Bao, Phillip M. Pifer, David Molkentine, Jessica M. Molkentine, Andrew Hefner +9 more

Molecular parameters impacting the success rate of a lung cancer PDX model.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e20592

N/A

0DataRank · unranked

0 citations

Shawna M. Hubert, Ran Zhang, Xingzhi Song, Tatiana V. Karpinets, Annikka Weissferdt +15 more

CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance

Cancer Cell(2023)10.1016/j.ccell.2023.01.007

N/A

0DataRank · unranked

104 citations

Yan Yang, Simon Heeke, Sonia Patel, Alissa Poteete, Hibiki Udagawa +22 more

Deep learning‐based pathology image analysis predicts cancer progression risk in patients with oral leukoplakia

Cancer Medicine(2023)10.1002/cam4.5478

N/A

0DataRank · unranked

40 citations

Frederico O. Gleber‐Netto, Shidan Wang, Roberta Rayra Martins‐Chaves, Ricardo Santiago Gomez, Nadarajah Vigneswaran +15 more

Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non–small cell lung cancer

Journal of Thoracic and Cardiovascular Surgery(2023)10.1016/j.jtcvs.2023.09.073

N/A

0DataRank · unranked

21 citations

Boris Sepesi, Cheuk Hong Leung, Heather Lin, Annikka Weissferdt, Apar Pataer +15 more

Pneumonitis After Concurrent Chemoradiation and Immune Checkpoint Inhibition in Patients with Locally Advanced Non-small Cell Lung Cancer

Clinical Oncology(2023)10.1016/j.clon.2023.07.003

N/A

0DataRank · unranked

20 citations

Felipe Soto, Ting Xu, Nathaniel R. Wilson, Maria Franco-Vega, C.A. Simbaqueba Clavijo +18 more

Spatial PD‐L1, immune‐cell microenvironment, and genomic copy‐number alteration patterns and drivers of invasive‐disease transition in prospective oral precancer cohort

Cancer(2023)10.1002/cncr.34607

N/A

0DataRank · unranked

14 citations

Jianjun Zhang, Xin Zhao, Edwin R. Parra, Naohiro Uraoka, Heather Lin +16 more

Unfolding the secrets of small cell lung cancer progression: Novel approaches and insights through rapid autopsies

Cancer Cell(2023)10.1016/j.ccell.2023.08.007

N/A

0DataRank · unranked

8 citations

Simon Heeke, Benjamin J. Drapkin, Anna Solta, Ildikó Kovács, Kristiina Boettiger +16 more

Effects of KRAS Genetic Interactions on Outcomes in Cancers of the Lung, Pancreas, and Colorectum

Cancer Epidemiology Biomarkers & Prevention(2023)10.1158/1055-9965.epi-23-0262

N/A

0DataRank · unranked

6 citations

John V. Heymach, Kenneth L. Kehl, Scott Kopetz, Ken S. Lau, Gregory J. Riely +5 more

Case Report: Immune checkpoint inhibitor–induced multiorgan vasculitis successfully treated with rituximab

Frontiers in Nephrology(2023)10.3389/fneph.2023.1168614

N/A

0DataRank · unranked

5 citations

Naszrin Arani, Vishnu P. Parvathareddy, Amanda Tchakarov, Maen Abdelrahim, María E. Suarez‐Almazor +6 more

A novel statistical method for decontaminating T-cell receptor sequencing data

Briefings in Bioinformatics(2023)10.1093/bib/bbad230

N/A

0DataRank · unranked

3 citations

Mehmet Altan, Alexandre Reuben, Ruitao Lin, John V. Heymach, Hai T. Tran +6 more

YAP1 status defines two intrinsic subtypes of LCNEC with distinct molecular features and therapeutic vulnerabilities

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.19.572449

N/A

0DataRank · unranked

1 citations

Lixia Diao, Yuanxin Xi, Runsheng Wang, Kavya Ramkumar, Alejandra G. Serrano +23 more

Data from AXL Inhibition Induces DNA Damage and Replication Stress in Non–Small Cell Lung Cancer Cells and Promotes Sensitivity to ATR Inhibitors

(2023)10.1158/1541-7786.c.6545156.v1

N/A

0DataRank · unranked

0 citations

C. Allison Stewart, Kasey R. Cargill, Carminia Maria Della Corte, Qi Wang, Li Shen +10 more

Analysis of tumor- and circulating-free DNA methylation to identify clinically relevant small cell lung cancer subtypes.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.8577

N/A

0DataRank · unranked

0 citations

Carl M. Gay, Marcos R. Estecio, Hai T. Tran, Benjamin B. Morris, Bingnan Zhang +15 more

Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non‑Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast

Targeted Oncology(2023)10.1007/s11523-023-01020-1

N/A

0DataRank · unranked

0 citations

Eric Nadler, Daniel B. Costa, John V. Heymach, Xiuning Le

An atlas of epithelial cell states and plasticity in lung adenocarcinoma

Nature(2024)10.1038/s41586-024-07113-9

N/A

0DataRank · unranked

163 citations

Ansam Sinjab, Zahraa Rahal, Anne M. Lynch, Warapen Treekitkarnmongkol, Yuejiang Liu +33 more

Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes

Cancer Cell(2024)10.1016/j.ccell.2024.01.001

N/A

0DataRank · unranked

116 citations

Carl M. Gay, Marcos R. Estecio, Hai T. Tran, Benjamin B. Morris, Bingnan Zhang +37 more

Mechanisms of Response and Tolerance to Active RAS Inhibition in KRAS -Mutant Non–Small Cell Lung Cancer

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0421

N/A

0DataRank · unranked

67 citations

Ximo Pechuan-Jorge, Teng Zhou, Minh Truong, Xin Hu, Frank Rojas +22 more

638P Final results of IMPACT 2, a randomized study evaluating molecular profiling and targeted agents in metastatic cancer at MD Anderson Cancer Center

Annals of Oncology(2024)10.1016/j.annonc.2024.08.705

N/A

0DataRank · unranked

1 citations

Siqing Fu, David S. Hong, S.A. Piha-Paul, A. Naing, J. Rodon +15 more

CoCo-ST: Comparing and Contrasting Spatial Transcriptomics data sets using graph contrastive learning

Research Square(2024)10.21203/rs.3.rs-4359834/v1

N/A

0DataRank · unranked

0 citations

Muhammad Aminu, Bo Zhu, Natalie I. Vokes, Hong Chen, Lingzhi Hong +18 more

Impact of Co-mutations and Transcriptional Signatures in Non–Small Cell Lung Cancer Patients Treated with Adagrasib in the KRYSTAL-1 Trial

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-2310

N/A

0DataRank · unranked

21 citations

Alvaro G. Paula, David Molkentine, Laura D. Hover, Monique B. Nilsson, Natalie I. Vokes +17 more

Rapid Intracranial Response With Tarlatamab in Patients With Untreated Brain Metastases From SCLC—A Real-World Case Series: Case Report

Journal of Thoracic Oncology(2025)10.1016/j.jtho.2025.02.023

N/A

0DataRank · unranked

17 citations

Komal Shah, Mitchell Parma, Kaiwen Wang, Eric K. Singhi, Whitney E. Lewis +23 more

The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study

Annals of Oncology(2025)10.1016/j.annonc.2025.09.140

N/A

0DataRank · unranked

8 citations

Y. Xia, Ke Pan, Fangdi Sun, Aaron C. Tan, Xinran Dong +31 more

Poziotinib for EGFR exon 20-insertion NSCLC: Clinical efficacy of the phase 2 ZENITH trial and differential impact of EGFR exon 20 insertion location on sensitivity

Nature Communications(2025)10.1038/s41467-025-61817-8

N/A

0DataRank · unranked

7 citations

Jacqulyne Robichaux, Monique B. Nilsson, R. S. K. Vijayan, Ashwin Ravichandran, Jia Wu +21 more

Intratumoral neutrophil-to-lymphocyte ratio is mirrored by circulating neutrophil-to-lymphocyte ratio in non-small cell lung cancer

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-011458

N/A

0DataRank · unranked

5 citations

Young‐Hee Lee, Nathaniel Deboever, Marcelo V. Negrão, Hai T. Tran, Edwin Parra +17 more

Osimertinib activates a TGF-β2–dependent secretory program that drives lung adenocarcinoma progression

Journal of Clinical Investigation(2025)10.1172/jci198418

N/A

0DataRank · unranked

2 citations

Chao Wu, Abhishek Kumar, Monique B. Nilsson, John V. Heymach, Weina Zhao +12 more

YAP1 defines an emergent, plastic population of relapsed small cell lung cancer

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.21.683746

N/A

0DataRank · unranked

0 citations

Kavya Ramkumar, Runsheng Wang, Yuanxin Xi, Alexa Halliday, Lixia Diao +19 more

John V. Heymach

Indexed papers

Top data-sharing exemplar

Papers